Fidelity International
SCLN

Fidelity International’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Fidelity International’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40,578
Closed -$207K – 630
2014
Q1 		$207K Buy
+40,578
New +$196K ﹤0.01% 606
2013
Q4 		– Sell
-40,578
Closed -$206K – 588
2013
Q3 		$206K Buy
+40,578
New +$226K ﹤0.01% 538

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Fidelity International's SCLN Position: Q2 2014 in Review

Fidelity International sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2014, closing a stake of 40,578 shares — an estimated $207K sold.

Fidelity International first reported a position in SCLN in Q3 2013 and held it in 2 quarters. The position peaked at $207K in Q1 2014. 95 funds tracked by Wall St. Rank hold SCLN as of Q2 2014.

  • Fidelity International reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Fidelity International sold 40,578 Sciclone Pharmaceuticals Inc shares in Q2 2014, an estimated $207K.
  • Fidelity International first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 2 quarters.
  • Fidelity International's Sciclone Pharmaceuticals Inc position peaked at $207K in Q1 2014.
  • 95 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2014.

Based on Fidelity International's 13F filing for Q2 2014, filed 14 Aug 2014.